Drug Trial Radar · NCT00081380
Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
Last checked: Nov 19, 2026Latest source record: Dec 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
710
Actual
Start
Mar 2004
Primary completion
Not stated
Study completion Sep 2006
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Apr 19, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar I Disorder. The study consists of enrollment and 2 phases, the Open-label treatment Phase and the Randomized treatment Phase. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Conditions
- Bipolar Disorder
Interventions
Seroquel®, quetiapine fumarate (atypical antipsychotic)Drug
lithium (mood stabilizer)Drug
divalproex (mood stabilizer)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the efficacy of quetiapine versus placebo when used as adjunct therapy to mood stabilizer in increasing time to recurrence of a mood event.
Locations
94 sites in 2 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Scottsdale, Arizona
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Cerritos, California
Research Site
Chula Vista, California
Research Site
Culver City, California
Research Site
Garden Grove, California
Research Site
La Mesa, California
Research Site
Oceanside, California
Research Site
Orange, California
Research Site
Pico Rivera, California
Research Site
Riverside, California
Research Site
Rosemead, California
Research Site
San Diego, California
Research Site
San Francisco, California
Research Site
Santa Ana, California
Research Site
Farmington, Connecticut
Research Site
New Britain, Connecticut
Research Site
Jacksonville, Florida
Research Site
Miami, Florida
Research Site
Orlando, Florida
Research Site
West Palm Beach, Florida
Research Site
Winter Park, Florida
Research Site
Atlanta, Georgia
Research Site
Decatur, Georgia
Research Site
Marietta, Georgia
Research Site
Smyrna, Georgia
Research Site
Honolulu, Hawaii
Research Site
Chicago, Illinois
Research Site
Hoffman Estates, Illinois
Research Site
Joliet, Illinois
Research Site
Evansville, Indiana
Research Site
Greenwood, Indiana
Research Site
Indianapolis, Indiana
Research Site
Wichita, Kansas
Research Site
Florence, Kentucky
Research Site
Lake Charles, Louisiana
Research Site
New Orleans, Louisiana
Research Site
Shreveport, Louisiana
Showing 40 of 94 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.